The study also showed that apigenin inhibits isoproterenol-induced myocardial fibrosis in mice via enhancing the antioxidant’s capacity to exert its antifibrotic effects, and it also decreases the NF-κB/TGF-β1 signaling pathway axis [140]. This evidence concerns the gene NFKB1 and Myocardial fibrosis.